Tools help clients comply with aggregate spend reporting and maintain a customer database.

Cegedim Dendrite and Capgemini agreed to jointly offer software solutions as well as consulting and technology services to life science firms. Specifically, Capgemini will provide consulting and implementation services associated with Cegedim Dendrite’s AggregateSpend360™ and Nucleus 360™ tools.

AggregateSpend360 enables compliance with changing regulations. Nucleus 360 establishes a master definition of the customer in a centralized repository and implements data governance and quality processes.

Through the alliance, biotech, pharma, and medical device firms will be able to take advantage of the combination of Cegedim Dendrite software and Capgemini’s expertise in industry best practices. The companies will work together to help clients confront the challenges of complying with an increasing number of complex federal and state requirements for disclosure reporting on marketing, clinical, advertising, and sales promotion expenses, commonly known as aggregate spend reporting.

Additionally, maintaining an accurate customer database when customer data is housed in multiple databases from disparate systems will also be enabled.

Previous articleInvestigators Elucidate Genetic Differences in Those Who Develop Meningitis
Next articleSigma Life Science and SwitchGear Genomics to Develop miRNA Target-Validation System